Approval · Notice of Compliance 17926 · 2016
XIAFLEX: Notice of Compliance 17926
Issued March 24, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17926
- Date
- March 24, 2016
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XIAFLEX | Not yet assigned | — |
Medicinal ingredients
- COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 0.9 MG per VIAL